CLINICAL_TRIALS
trial_result
· 2021-08-27
Clinical Trial Update: A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis [Phase 2]
Summary
Phase 2 trial evaluating safety and efficacy of PF-06826647 for moderate to severe plaque psoriasis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2021-08-27